|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400084527 |
|
最近更新日期: Date of Last Refreshed on: |
2024-05-20 10:41:01 |
|
注册时间: Date of Registration: |
2024-05-20 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
ICU重症康复现况调查 |
|
Public title: |
Investigation on the status of rehabilitation of critically ill patients in ICU |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
ICU重症康复现况调查 |
|
Scientific title: |
Investigation on the status of rehabilitation of critically ill patients in ICU |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
牛昕妤 |
研究负责人: |
李双玲 |
|
Applicant: |
Niu Xinyu |
Study leader: |
Li Shuangling |
|
申请注册联系人电话: Applicant telephone: |
+86 83575677 |
研究负责人电话: Study leader's telephone: |
+86 83575677 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
lanxyzy@aliyun.com |
研究负责人电子邮件: Study leader's E-mail: |
ling888@hotmail.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市西城区西什库大街8号 |
研究负责人通讯地址: |
北京市西城区西什库大街8号 |
|
Applicant address: |
No.8 Xishiku Street, Xicheng District, Beijing,China |
Study leader's address: |
No.8 Xishiku Street, Xicheng District, Beijing,China |
|
申请注册联系人邮政编码: Applicant postcode: |
100034 |
研究负责人邮政编码: Study leader's postcode: |
100034 |
|
申请人所在单位: |
北京大学第一医院 |
||
|
Applicant's institution: |
Peking University First Hospital |
||
|
研究负责人所在单位: |
北京大学第一医院 |
||
|
Affiliation of the Leader: |
Peking University First Hospital |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2024研014-002 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
北京大学第一医院生物医学研究伦理委员会 |
||
|
Name of the ethic committee: |
Biomedical Research Ethics Committee of Peking University First Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-03-04 00:00:00 |
||
|
伦理委员会联系人: |
于岩岩 |
||
|
Contact Name of the ethic committee: |
Yu Yanyan |
||
|
伦理委员会联系地址: |
Yu Yanyan |
||
|
Contact Address of the ethic committee: |
No.8 Xishiku Street, Xicheng District, Beijing,China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 66119025 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
北京大学第一医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Peking University First Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市西城区西什库大街8号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.8 Xishiku Street, Xicheng District, Beijing,China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
self-funded |
||||||||||||||||||||||
|
Target disease: |
Recovery of critically ill patients in ICU |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
深入全面了解我国ICU重症康复的现状,更好地开展重症康复的临床应用实践,改善ICU患者的预后。 |
||||||||||||||||||||||
|
Objectives of Study: |
To gain insight into the current state of ICU rehabilitation in China, in order to enhance the implementation of clinical practices for ICU rehabilitation and ultimately improve the prognosis of ICU patients. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
研究将采用多阶段分层抽样,分为三个阶段。 在第一阶段,明确将中国大陆的各省、市、自治区纳入调查的范围。考虑因素:根据各省的人口规模分为两组:以占全国人口的4%为标准,区分人口大省和人口小省。31个省(市、自治区)可分为10个人口大省和21个人口小省。 第二阶段,从每个省份所有三级医院中进行便利抽样。每个人口大省选择18家三级医院,每个人口小省选择9家三级医院,共计369家三级医院。如果抽样后的医院或医院ICU 负责人拒绝参与研究,则重新进行抽样过程。 第三阶段,向抽样后得到的三级医院的ICU实际负责人定点发放问卷。 |
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
This study uses multistage stratified sampling in three phases. In the first stage, 31 provinces in China are included in the survey. Provinces are divided into two groups according to their population size, large and small provinces. Large and small provinces are distinguished using 4% of the national population as the standard. Those provinces (cities, autonomous regions) are divided into 10 provinces with large population and 21 provinces with small population. In the second phase, convenience sampling is conducted from all tertiary hospitals in each province. 18 tertiary hospitals are selected in each province with large population, and 9 hospitals are selected in each province with small population, for a total of 369 tertiary hospitals. In cases where hospital or ICU leaders decline to participate after being sampled, the sampling process is repeated. In the third stage, questionnaires are distributed to the actual responsible persons of ICU in tertiary hospitals. |
||||||||||||||||||||||
|
纳入标准: |
(1)主持ICU工作的负责人(2)自愿参与本研究,并签署知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) The person in charge of the ICU work (2) voluntarily participated in this study and signed the informed consent. |
||||||||||||||||||||||
|
排除标准: |
因请假等因素暂离临床工作3个月及以上。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Temporary absence from clinical work for 3 months or more due to leave and other factors. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-05-22 00:00:00至 To 2025-06-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-05-23 00:00:00 至 To 2025-05-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
随机数表法 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Random number table method |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
no |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
调查问卷 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
questionnaire |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |